These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29962113)

  • 1. Case report: A transplant candidate with unexpected serum reactivity against the 45KE eplet on HLA-B alleles.
    Cauquil B; Dautin G; Duquesnoy RJ
    HLA; 2018 Oct; 92(4):231-232. PubMed ID: 29962113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant.
    Resse M; Paolillo R; Casamassimi A; Cavalca F; Fiorito C; Maiello C; Napoli C
    Hum Immunol; 2013 Aug; 74(8):937-41. PubMed ID: 23628396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should epitope-based HLA compatibility be used in the kidney allocation system?
    Duquesnoy RJ
    Hum Immunol; 2017 Jan; 78(1):24-29. PubMed ID: 27771385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are We Ready for Epitope-Based HLA Matching in Clinical Organ Transplantation?
    Duquesnoy RJ
    Transplantation; 2017 Aug; 101(8):1755-1765. PubMed ID: 28207632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.
    Duquesnoy RJ; Awadalla Y; Lomago J; Jelinek L; Howe J; Zern D; Hunter B; Martell J; Girnita A; Zeevi A
    Transpl Immunol; 2008 Feb; 18(4):352-60. PubMed ID: 18158123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies.
    Duquesnoy RJ; Marrari M; Mulder A; Claas FH; Mostecki J; Balazs I
    Hum Immunol; 2012 Mar; 73(3):267-77. PubMed ID: 22227099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward defining the immunogenicity of HLA epitopes: Impact of HLA class I eplets on antibody formation during pregnancy.
    Hönger G; Niemann M; Schawalder L; Jones J; van Heck MR; van de Pasch LAL; Vendelbosch S; Rozemuller EH; Hösli I; Blümel S; Schaub S
    HLA; 2020 Nov; 96(5):589-600. PubMed ID: 32829523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Antibody-Mediated Rejection by De Novo Anti-HLA-DPβ and -DPα Antibodies After Kidney Transplantation: A Case Report.
    Thammanichanond D; Parapiboon W; Mongkolsuk T; Worawichawong S; Tammakorn C; Kitpoka P
    Transplant Proc; 2018 Oct; 50(8):2548-2552. PubMed ID: 30316396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
    Otten HG; Calis JJ; Keşmir C; van Zuilen AD; Spierings E
    Hum Immunol; 2013 Mar; 74(3):290-6. PubMed ID: 23232063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How did a patient who types for HLA-B*4403 develop antibodies that react with HLA-B*4402?
    Lomago J; Jelenik L; Zern D; Howe J; Martell J; Zeevi A; Duquesnoy RJ
    Hum Immunol; 2010 Feb; 71(2):176-8. PubMed ID: 19963027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
    Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
    Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of epitopes on HLA-DRB alleles reacting with antibodies in sera from women sensitized during pregnancy.
    Duquesnoy RJ; Hönger G; Hösli I; Marrari M; Schaub S
    Hum Immunol; 2016 Feb; 77(2):214-22. PubMed ID: 26686763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes.
    Bezstarosti S; Kramer CSM; Claas FHJ; de Fijter JW; Reinders MEJ; Heidt S
    Hum Immunol; 2022 Mar; 83(3):256-263. PubMed ID: 34963506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity.
    Duquesnoy RJ
    Int J Immunogenet; 2012 Feb; 39(1):1-9. PubMed ID: 21981757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-defined epitopes on HLA-DQ alleles reacting with antibodies induced during pregnancy and the design of a DQ eplet map.
    Duquesnoy RJ; Hönger G; Hösli I; Marrari M; Schaub S
    Hum Immunol; 2016 Oct; 77(10):824-831. PubMed ID: 27374949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared molecular eplet stimulates acute antibody-mediated rejection in a kidney transplant recipient with low-level donor-specific antibodies: a case report.
    Mongkolsuk T; Ingsathit A; Worawichawong S; Jirasiritham S; Kitpoka P; Thammanichanond D
    Transplant Proc; 2014; 46(2):644-7. PubMed ID: 24656035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients.
    Ravindranath MH; Pham T; Ozawa M; Terasaki PI
    Int Immunol; 2012 Jan; 24(1):43-57. PubMed ID: 22190577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.